Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria.

Details

Language :

English

ISSN :

0732183X

Volume :

32

Issue :

3

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

104009734

Full Text :

https://doi.org/10.1200/JCO.2013.50.3110